Ex-FDA Head Says AbbVie Promoted Off-Label Androgel Use

By Jessica Corso (June 6, 2017, 5:40 PM EDT) -- Former U.S. Food and Drug Administration Commissioner David Kessler told jurors Tuesday that he felt AbbVie Inc. had stepped outside the bounds placed on it by the FDA by promoting testosterone replacement therapy drug Androgel for use in aging men without testing the safety of the drug....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!